临床普外科电子杂志 ›› 2023, Vol. 11 ›› Issue (1): 5-.

• • 上一篇    下一篇

腹腔镜下全直肠系膜切除术治疗直肠癌的优势

  

  1. 徐州医科大学附属沭阳医院 普通外科,江苏 沭阳 223600
  • 出版日期:2023-01-01 发布日期:2023-03-06
  • 基金资助:

    2020 年度徐州医科大学江苏省重点实验室开放课题资助项目(XZSYSKF2020007)

Study on the advantages and safety of laparoscopic total mesorectal excision for rectal cancer

  1. General Surgery Department of Shuyang Hospital Affiliated to Xuzhou Medical University, Jiangsu Shuyang 223600, China
  • Online:2023-01-01 Published:2023-03-06

摘要:

目的 探讨腹腔镜下全直肠系膜切除术治疗直肠癌患者的临床效果与安全性。方法 选取2020年8 月至2022 年3 月徐州医科大学附属沭阳医院收治的直肠癌患者69 例,采取红蓝小球随机抽签方式划分对照组(蓝色球,34 例)与观察组(红色球,35 例),对照组患者采取开腹全直肠系膜切除术治疗,观察组患者实施腹腔镜下全直肠系膜切除术治疗,记录比较两组患者手术指标及术后恢复用时差异,统计两组患者发生术后并发症的发生率。结果 观察组手术总时长(181.23±15.21)min 长于对照组(t=15.285,P < 0.05),淋巴结清扫数目与对照组比较无显著差异(t=0.113,P > 0.05)。此外,观察组患者术后出现并发症的总发生率2.86% 低于对照组的23.53%(χ2=4.803,P < 0.05)。结论 治疗直肠癌疾病可首选腹腔镜下全直肠系膜切除术,其优点在于对患者造成伤害小,术后恢复快,同时并发症少,安全性理想。

关键词: 腹腔镜下全直肠系膜切除术, 直肠癌, 手术指标, 并发症

Abstract:

Objective To investigate the clinical efficacy and safety of laparoscopic total mesorectal excision (LME) for rectal cancer. Method From August 2020 to March 2022, 69 rectal cancer patients in Shuyang Hospital Affiliated to Xuzhou Medical University were selected and analyzed. The control group (blue ball, 34 cases) and the observation group (red ball, 35 cases) were randomly divided by red blue ball. The control group was treated by open total mesorectal excision, and the observation group was treated by laparoscopic total mesorectal excision, Record and compare the difference of operation indexes and recovery time of patients in each group, and observe and count the probability of postoperative complications of patients in the two groups. Result The total operation time (181.23 ± 15.21) min in the observation group was longer than that in the control group (t=15.285, P < 0.05),

and the number of lymph node dissection (14.02 ± 4.02) had no significant difference compared with the control group (t=0.113, P > 0.05). In addition, the total probability of postoperative complications in the observation group was 2.86% lower than that in the control group (χ2= 4.803,P < 0.05). Conclusion Laparoscopic total mesorectal excision is the first choice for clinical treatment of rectal cancer, which has the advantages of less damage to patients, rapid recovery, fewer complications and ideal safety.

Key words: Laparoscopic total mesorectal excision, Rectal cancer, Surgical indicators, Complication